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Polymicrobial inter-kingdom biofilm infections represent a clinical management
conundrum. The presence of co-isolation of bacteria and fungi complicates the
ability to routinely administer single antimicrobial regimens, and synergy between the
microorganisms influences infection severity. We therefore investigated the nosocomial
pathogens Staphylococcus aureus and Candida albicans with respect to antimicrobial
intervention. We characterized the interaction using biofilm assays and evaluated the
effect of miconazole treatment using in vitro and in vivo assays. Finally, we assessed the
impact of biofilm extracellular matrix (ECM) on these interactions. Data indicated that the
C. albicans mycofilms supported adhesion and colonization by S. aureus through close
interactions with hyphal elements, significantly increasing S. aureus biofilm formation
throughout biofilm maturation. Miconazole sensitivity was shown to be reduced in
both mono- and dual-species biofilms compared to planktonic cells. Within a three-
dimensional biofilm model sensitivity was also hindered. Galleria mellonella survival
analysis showed both enhanced pathogenicity of the dual-species infection, which was
concomitantly desensitized to miconazole treatment. Analysis of the ECM revealed the
importance of extracellular DNA, which supported the adhesion of S. aureus and the
development of the dual-species biofilm structures. Collectively, these data highlight
the clinical importance of dual-species inter-kingdom biofilm infections, though also
provides translational opportunities to manage them more effectively.
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INTRODUCTION
Despite their clinical significance, polymicrobial biofilm infections continue to be a widely
understudied health problem. Advancement in biofilm research has highlighted that these cellular
communities are rarely composed of a single-species consortia, but instead exist as complex,
diverse, and heterogeneous structures (Peleg et al., 2010). By actively participating within these
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environments different micro-organisms can interact at a
mechanistic level through direct and indirect exchanges of both
a physical and chemical nature. This can ultimately influence
disease severity by promoting intensified pathogenic phenotypes
(Peters et al., 2010), including increased recalcitrance to both
host defenses and antimicrobial therapies (Kart et al., 2014).
Although belonging to distinct phylogenetic kingdoms, the
dimorphic fungus Candida albicans and the bacterial pathogen
Staphylococcus aureus possess the ability to habitually co-exist as
complex polymicrobial biofilms within the human host, and are
therefore key exemplars of polymicrobiality.
Staphylococcus aureus and C. albicans are defined as the
second and fourth most commonly cultured organisms from
bloodstream infections within the USA (Wisplinghoff et al.,
2004). An estimated 27% of candidaemia infections are
polymicrobial, with S. aureus representing the third most
frequently co-isolated organism (Klotz et al., 2007). Duality of
infection is also frequently observed in co-infections of burn
wounds and cystic fibrosis, as well from the surface of indwelling
medical devices such as dentures, prosthetic joints and implants,
and more commonly catheters (Valenza et al., 2008; Peters et al.,
2012a). Mechanistically, there is evidence to suggest that this
interaction is multifaceted, intricately linked to biofilm-phased
development. Initial attachment of S. aureus to C. albicans
hyphae appears to be mediated by C. albicans agglutinin like
sequence 3 protein (Als3p; Peters et al., 2012b). As the biofilm
develops, quorum sensing (QS) molecules have been shown
to exhibit both synergistic and antagonistic effects, with either
organism secreting reciprocal QS molecules to positively and
negatively influence biofilm growth (Jabra-Rizk et al., 2006;
Lin et al., 2013). Structurally, the extracellular matrix (ECM)
of C. albicans has been shown to advantageously support
these dual-species biofilms through prevention of diffusion of
vancomycin to access S. aureus, with the bacteria potentially
encasing itself within this polymeric material (Harriott and
Noverr, 2009). Furthermore, it has now been shown that the
fungal specific matrix component β-1,3-glucan promotes this
vancomycin resistance (Kong et al., 2016). However, how these
biofilms respond to antifungal agents remains undefined.
Candida albicans biofilms are notoriously resistant to
antifungal agents, displaying up to 1000-fold increases in
resistance to azoles compared to their planktonic counterparts
(Ramage et al., 2001). Triazoles, such as fluconazole, represent
the first-line option for C. albicans infections, though are
often ineffectual against C. albicans biofilms (Sherry et al.,
2014; Rajendran et al., 2016b). However, unlike these more
commonly used triazoles, the imidazole miconazole appears to
display fungicidal activity against C. albicans biofilms in vitro
(Vandenbosch et al., 2010). This same agent has also been
shown to display antibacterial activity against a range of Gram-
positive bacteria, including S. aureus (Nobre et al., 2010). We
therefore sought to evaluate the in vitro and in vivo efficacy
of miconazole against C. albicans and S. aureus dual-species
biofilms, and aimed to understand the contribution of the ECM
in this interaction. Here we report that C. albicans mycofilms
actively enhance S. aureus colonization and negatively impacts
miconazole sensitivity.
MATERIALS AND METHODS
Microbial Growth and Standardization
Candida albicans SC5314 strain and the biofilm defective
Staphylococcus aureus Newman strain were used throughout the
duration of this study (Duthie and Lorenz, 1952; Fonzi and Irwin,
1993; Beenken et al., 2003). C. albicans SC5314 was grown and
maintained on Sabouraud’s dextrose agar (Oxoid, Hampshire,
UK) and incubated at 30◦C for 48 h. Yeast cells were propagated
by inoculating yeast peptone dextrose (YPD) media (Sigma–
Aldrich, Dorset, UK) with a loopful of colonies and incubated at
30◦C at 200 rpm in an orbital shaker overnight. After growth,
cells were pelleted by centrifugation and washed in phosphate
buffered saline [PBS (Sigma–Aldrich, Dorset, UK)] before being
standardized in selected media at assay specific concentration
requirements after cells were counted using a haemocytometer.
The S. aureus Newman strain was cultured and maintained
on Luria Bertani agar at 37◦C for 48 h. S. aureus cells were
propagated overnight in Luria Bertani broth at 37◦C before
being washed by centrifugation in PBS. Following cell washing,
they were standardized in selected media to assay specific
concentration requirements after their density was determined
using a colorimeter.
Development of Dual-Species Biofilm
Model
Both C. albicans and S. aureus were standardized to 1 × 106
cells/mL in 50% v/v foetal bovine serum (FBS) diluted in sterile
water. Biofilms were formed at 37◦C over 1.5 (90 min), 6
and 24 h by adding both organisms 1:1 to either microtiter
plates (Corning, NY, USA) or 13 mm diameter ThermanoxTM
coverslips (Fisher Scientific, Loughborough, UK), depending on
the assay function. Mono-species biofilms and appropriate media
controls were run in parallel for each experimental condition
assessed. Following incubation media was discarded and biofilms
were washed with PBS to remove any non-adherent cells. The
biomass of each biofilm was quantified by the crystal violet
(CV) assay described previously (Sherry et al., 2014). The
CV absorbance was then measured spectrophotometrically at a
wavelength of 570 nm using a microtiter plate reader (FLUOStar
Omega, BMG Labtech, Aylesbury, UK).
Biofilm Composition and Viability
Analysis
Biofilm composition was enumerated using live/dead PCR,
a technique also able to differentiate between total and live
cells using methodologies previously described by our group
(Townsend et al., 2016). Biofilms were grown as above on
ThermanoxTM coverslips (Fisher Scientific, Loughborough, UK),
washed in PBS, and sonicated in 1 mL of PBS at 35 kHz in
an ultrasonic water-bath (Fisher Scientific, Loughborough, UK)
for 15 min to remove the biofilm. Next, 50 µM of propidium
monoazide [PMA (Cambridge Bioscience, Cambridge, UK)] was
added to the sample and incubated for 10 min in the dark to
allow uptake of the dye. PMA-free controls were also included
to determine total cell number. All samples were then exposed
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to a 650 W halogen light for 5 min before DNA was extracted
using the QIAamp DNA mini kit, as per manufacturer’s protocol
(Qiagen, Crawley, UK). Real-time quantitative PCR (qPCR) was
then used to determine the live and total cell number within
each biofilm. Briefly, 1 µL of extracted DNA was added to
a PCR mastermix containing Fast SYBR R© Green Master Mix,
10 µM species-specific forward and reverse primers (Table 1),
and RNase free water. qPCR was then carried out using the Step-
One plus real time PCR machine (Life Technologies, Paisley, UK)
using the following thermal profile: 50◦C for 2 min, 95◦C for
2 min, followed by 40 cycles of 95◦C for 3 s and 60◦C for 30 s.
Colony forming equivalents (CFE) were calculated compared
to a standard curve of serially diluted DNA of each species as
previously described (O’Donnell et al., 2016).
Dual-Species Biofilm Visualization
Mono- and dual-species biofilms were stained with 5 µM
calcofluor white (Invitrogen, Paisley, UK) and 20 µM SYTO9 R©
(Sigma–Aldrich, Dorset, UK) was used to stain both fungal
and bacterial cells. Biofilms were then imaged using a confocal
laser scanning microscopy (CLSM) microscope (Leica SP5 laser
scanning confocal microscope) at an excitation and emission
wavelength of 350 and 400 nm for calcofluor white and 485
and 500 nm for SYTO9 R©. Images were then processed and
analyzed using Volocity 3D Image Analysis Software (Perkin
Elmer). In addition, biofilms were also imaged using scanning
electron microscopy (SEM). After biofilm development, biofilms
were fixed using 2% para-formaldehyde, 2% glutaraldehyde,
0.15 M sodium cacodylate, and 0.15% w/v alcian blue and
processed for SEM, as previously described (Erlandsen et al.,
2004). Samples were then sputter coated in gold before
being imaged using a JEOL JSM-6400 scanning electron
microscope.
In vitro Biofilm Susceptibility Testing
Simple mono- and dual-species biofilms were grown in microtiter
wells for 24 h before being challenged for a subsequent 24 h with
serially twofold diluted concentrations of miconazole (Sigma–
Aldrich, Dorset, UK), ranging from 320 to 0.63 mg/L using
standardized biofilm testing methodology to determine the
sessile minimum inhibitory concentration (SMIC; Sherry et al.,
2014). Planktonic MIC (PMIC) testing was also performed on
single- and dual-species inoculum using standard CLSI broth
microdilution testing (CLSI, 2012). In addition, these biofilms
were also treated with miconazole± DNase I [130 mg/L (Sigma–
Aldrich, Dorset, UK)], lyticase, and chitinase [50 mg/L (Sigma–
Aldrich, Dorset, UK)]. Following treatment the proportional
viability was calculated in each test condition compared to
an untreated control using the XTT metabolic reduction assay
(Pierce et al., 2008).
In parallel, we prepared complex three-dimensional mono-
and dual-species biofilms for 24 h on a 3D cellulose matrix
model recently optimized and described by our group (Townsend
et al., 2016). After growth, biofilms were gently washed with
PBS before being treated with 40 mg/L of miconazole for a
further 24 h. Following treatment, biofilms were washed before
being sonicated for 5 min in 1 mL of PBS at 35 kHz in an
ultrasonic water-bath (Fisher Scientific, Leicestershire, UK) to
remove biofilm cells, and the viability of the biofilms after
treatment was determined using species-specific live/dead PCR,
as described above.
Galleria mellonella Survival Assays
The pathogenicity of C. albicans, S. aureus, and co-infection was
assessed using the Galleria mellonella killing assay as previously
described (Rajendran et al., 2015). Sixth instar G. mellonella
larvae (Livefoods Direct Ltd, UK) with a body weight between
200 and 300 mg were used. For each group, 30 larvae were
injected directly into the hemocoel at a concentration of
5 × 105 CFU/larvae/organism (1 × 106 CFU/larvae total
for co-infection) through the hindmost right proleg region,
using a 50 µL Hamilton syringe with a 26 g needle. Larvae
were then placed in Petri dishes at 37◦C, with survival being
monitored across a 48 h period. Larvae were considered dead
when they displayed no movement in response to touch and
showed severe melanisation within the cuticle as previously
described (Sherry et al., 2014). To determine fungal and bacterial
burden after 24 h post-infection, three representative larvae
from each group were homogenized and DNA extracted as
described elsewhere (Rajendran et al., 2015). The fungal and
bacterial burden, expressed as CFE (CFE/100 mg body weight),
was then assessed using species-specific primers and standard
curves as described above. For antimicrobial treatment assays,
larvae were administered with miconazole in the hindmost
left proleg region 2 h post-infection of either mono- or dual-
species co-infection. A miconazole concentration of 75 mg/kg
body weight was used throughout this experiment. Appropriate
uninfected, drug only and vehicle controls were included for each
experiment.
Quantification of eDNA Release
The quantity of eDNA released into the biofilm supernatant
and ECM from C. albicans, S. aureus, and dual-species biofilms
was measured using a microplate fluorescence assay (MFA), as
previously described (Rajendran et al., 2014). Standardized cells
(1 × 106 cells/mL) were seeded in a black 96-well microtiter
plate (Corning, NY, USA) and SYBR R© Green I (Invitrogen,
Paisley, UK) added to the cells at a ratio of 1:10. The binding
of this dye results in fluorescence that is directly proportional
to the level of eDNA. These levels were then measured after
6, 12, and 24 h of growth using a microtiter plate reader at
excitation and emission wavelengths of 485 and 518 nm, and
eDNA quantified in comparison to a standard curve. Next,
in order to determine the quantity of eDNA contributing to
the ECM the biomass of 24 h grown biofilms was removed
using a cell scraper and then treated with 0.2 M EDTA to
extract the ECM. Samples were then centrifuged at 10,000 × g
and EDTA supernatants recovered. The quantity of ECM
associated eDNA was then calculated using the MFA described
above. In addition, DNA was precipitated from the isolated
matrix using ammonium acetate precipitation and species-
specific eDNA was quantified using qPCR as described above,
using fungal specific 18S and bacteria specific 16S primers
(Table 1).
Frontiers in Microbiology | www.frontiersin.org 3 February 2017 | Volume 8 | Article 258
fmicb-08-00258 February 22, 2017 Time: 16:15 # 4
Kean et al. Miconazole Resistance in Dual-Species Interactions
TABLE 1 | Primer sequences used for qPCR.
Primer Sequence (5′-3′) Reference
Candida albicans F – GAGCGTCGTTTCTCCCTCAAACCGCTGG R – GGTGGACGTTACCGCCGCAAGCAATGTT Alves et al., 2014
Staphylococcus aureus F – ATTTGGTCCCAGTGGTGTGGGTAT R – GCTGTGACAATTGCCGTTTGTCGT O’Donnell et al., 2016
18S F – CTCGTAGTTGAACCTTGGGC R – GGCCTGCTTTGAACACTCTA Sherry et al., 2016
16S F – CGCTAGTAATCGTGGATCAGAATG R – TGTGACGGGCGGTGTGTA Sherry et al., 2016
Staphylococcus aureus Mycofilm
Adherence Assay
For adhesion, 24 h grown C. albicans biofilms were
treated ± DNase I [130 and 650 mg/L (Sigma–Aldrich, Dorset,
UK)] prepared in a buffer solution containing 0.15 M NaCl with
5 mM MgCl2 for 4 h at 37◦C. S. aureus cells were standardized
to 1 × 106 CFU/mL before being stained with 20 µM SYTO9 R©
for 20 min, prior to excess dye being removed by centrifugation.
Biofilms were then washed again before the addition of the
fluorescently stained S. aureus cells to the C. albicans biofilm for
90 min. After incubation, biofilms were washed again to remove
any non-adherent S. aureus cells and SYTO9 R© fluorescence
quantified using plate reader at an excitation and emission
wavelengths of 485 and 518 nm, respectively. The number of
adherent cells was then quantified in comparison to a serially
diluted S. aureus standard curve.
Statistical Analysis
Graph production, data distribution, and statistical analysis were
performed using GraphPad Prism (version 5; La Jolla, CA, USA).
Student t-tests were used to analyze experiments comparing
independent sample data. Kaplan Meier survival curves were
analyzed using the log-rank test. Statistical significance was
achieved if P< 0.05.
RESULTS
Staphylococcus aureus Utilizes Candida
albicans Mycofilms as a Structural
Scaffold
First, we wanted to determine the basis of how C. albicans and
S. aureus interact within a biofilm environment. We purposely
used the Newman’s strain of S. aureus that has a defective
biofilm phenotype (Beenken et al., 2003; Supplementary Figure
1), working with the hypothesis that C. albicans biofilm structure
positively influenced its ability to colonize and form biofilms
irrespective of host derived substrates. Mono- and dual-species
biofilms were quantified at early (90 min), intermediate (6 h),
and mature (24 h) stages of biofilm growth using the CV
biomass assay (Figure 1A). It was shown that dual-species
biofilms contained significantly more biomass than either of
the mono-species organism’s biofilms at 90 min, 6 and 24 h
(p< 0.001). A sensitive quantitative molecular approach was then
used in order to assess both viability and composition of each
species within the dual-species biofilm throughout maturation.
After 90 min no statistical differences were observed in the
overall total and viable number of C. albicans between the
mono- and dual-species biofilms (p = 0.1021), though a 2.76-
and 3.92-fold increase in the total and live number of S. aureus
cells was observed within the dual-species biofilm, respectively
(Figure 1B). When scrutinized visually we observe C. albicans
cells existing as germ tubes with single and small clusters of
S. aureus cells adhered to these structures (Figure 1C). As the
biofilm progressed to the intermediate phase of growth at 6 h
no difference was observed in the total and live number of
C. albicans cells between mono- and dual-species biofilm cultures
(Figure 1B). Though, a significant S. aureus increase within
the dual-species biofilm was observed (p < 0.01, 24.11-fold),
which is reinforced microscopically where we observe enhanced
colonies of clustered S. aureus cells attached to the hyphae of
C. albicans (Figure 1C). Next, when we evaluated fully matured
24 h biofilms we observe similar trends as above (Figure 1B), with
no statistical difference between the total numbers of C. albicans
cells between both biofilms. Intriguingly though, when we
quantified the number of dead cells (total cells minus live cells)
we observed a statistically significant increase in the quantity
of dead C. albicans cells in the dual-species biofilm (p < 0.01,
2.52-fold). Conversely, S. aureus was significantly increased in
the dual-species biofilm compared to mono-species biofilms, with
total and viable cells number increasing 5.85- and 3.66-fold,
respectively (p< 0.05). Visually, these dual-species biofilms were
characterized by extensively spread micro-colonies of S. aureus
biofilm cells attached to and interspersed throughout the dense
network of C. albicans hyphal growth (Figure 1C). Collectively,
these data suggest that these two microorganisms display a
level of synergy given their intimate physical relationship, where
candidal mycofilms serve as the base substrate for S. aureus
colonization.
Dual-Species Biofilms Decrease
Miconazole Efficacy In vitro
First, we investigated the sensitivity of simple mono- and dual-
species planktonic and sessile cells using standardized metabolic
based methodologies. It was shown that the PMIC for S. aureus
was 1 mg/L and C. albicans and dual-species were 4 mg/L. The
SMIC80, i.e., the concentration that inhibited 80% metabolic
activity of the biofilm, was 10-fold greater for each biofilm tested,
with S. aureus mono-species biofilms at 10 mg/L, whereas for
both the C. albicans mono-species and the dual-species biofilms
at 40 mg/L (Table 2).
Next, we evaluated mono- and dual- species biofilms within
a more complex 3D wound model determined their sensitivity
against a 24 h treatment of miconazole (SMIC80 = 40 mg/L).
No significant differences were observed for C. albicans
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FIGURE 1 | Candida albicans mycofilms facilitates Staphylococcus aureus biofilm formation. Mono- and dual-species biofilms were standardized 1 × 106
CFU/mL and grown on 96-well plates for 90 min, 6 and 24 h. Biofilms were then washed with phosphate buffered saline (PBS) and biomass assessed using the
crystal violet assay (A). Standardized biofilms were grown before being sonicated to remove the biomass. Live/dead PCR was then used to extract DNA and
determine total and live colony forming equivalents (CFE) from mono- and dual-species biofilms (B). Biofilm morphology was then analyzed using CSLM. Biofilms
were grown before being fluorescently stained using calcofluor white and SYTO9 R© dyes. Resulting biofilms were then viewed on a Leica SP5 laser scanning confocal
microscope and images were then processed and analyzed using Volocity 3D Image Analysis Software (C). Results represent data from three independent
occasions. Statistical analysis compares dual-species biofilms to their mono-species equivalent (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). ##p < 0.01, compares dead
cells between dual- and mono-species biofilms.
TABLE 2 | Sessile MIC for miconazole in the presence and absence of hydrolytic enzymes.
Minimum inhibitory concentration (mg/L)
SMIC80
Miconazole Miconazole + DNase Miconazole + Lyticase Miconazole + Chitinase
C. albicans (CA) 40 40 40 40
S. aureus (SA) 10 10 10 10
CA+SA 40 20 40 40
post-treatment between mono- and dual-species biofilms
(Figure 2). However, there was decreased sensitivity observed
in S. aureus when grown in the dual-species biofilm, with
a significant 3.52-fold increase in the quantity of live cells
post-treatment (p< 0.01; Figure 2).
Dual-Species Biofilms Decrease
Miconazole Efficacy In vivo
In order to first establish whether any co-operative pathogenicity
exists between both organisms in vivo, a G. mellonella infection
model was utilized. Inoculation of larvae with C. albicans was
shown to kill approximately 60 and 80% of larvae after 24
and 48 h post-infection, respectively. Conversely, larvae co-
infected with both C. albicans and S. aureus demonstrated an
80 and 100% mortality rate after 24 and 48 h, respectively.
This was a significant increase compared to both C. albicans
(p < 0.05) only and S. aureus only (p < 0.001), the latter of
which was avirulent at the chosen cell concentration (Figure 3A
and Supplementary Figure 2). Three selected larvae were then
chosen to determine the microbial burden at 24 h post-infection.
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FIGURE 2 | Inter-kingdom interactions decrease Staphylococcus
aureus sensitivity to miconazole. Biofilms were grown for 24 h on a
cellulose matrix based hydrogel model before being washed with PBS and
treated with 40 mg/L of miconazole for a further 24 h. After treatment, the
cellulose matrix was removed and sonicated to dislodge the biofilm biomass.
Live/dead PCR was then used to extract DNA and quantify total and live CFE.
Data is presented as the CFE of live cells comparing treated mono- and
dual-species biofilms. Data represents duplicate samples from three
independent time points with significance achieved with ∗∗p < 0.01.
Results showed that C. albicans CFE counts remained at
equivalent levels in mono- and dual-infection. Whereas, as
observed with the in vitro data the quantity of S. aureus
was significantly enhanced 11.1-fold when co-infected with
C. albicans (p < 0.05; Figure 3B). These data indicate that when
in combination the pathogenic outcome is synergised in co-
infection, and given that S. aureus is quantitatively enhanced
then this would suggest C. albicans supports and enhances its
growth.
Next, we tested the efficacy of miconazole against this
synergised co-infection using the G. mellonella infection model.
Upon 2 h post-infection larvae were administered with
miconazole and mortality monitored over a 48 h period. Results
showed that after 24 h, over 75% of C. albicans infected larvae
remained alive after miconazole treatment, and almost 50%
survived 48 h after infection. All larvae remained alive at 48 h
post-inoculation with S. aureus. However, co-infection with both
organisms resulted in a loss of susceptibility to miconazole, with
mortality reaching almost 70% after 24 h and >85% at 48 h post-
infection, a significant difference in larvae survival compared to
C. albicans (p< 0.01) and S. aureus (p< 0.001) alone (Figure 3C).
Extracellular DNA Promotes Stability to
the ECM of Dual-Species Biofilms
When analyzed visually through SEM, clusters of S. aureus
biofilm can be seen embedded within C. albicans mycofilms
and associated with ECM (Figure 4). Given that ECM is an
important characteristic associated with antifungal resistance,
we hypothesized that degradation of ECM components in
combination with miconazole would enhance biofilm sensitivity.
It was shown that degradation of eDNA, β-1,3-glucan and chitin
had no effect on the MIC80 value for C. albicans and S. aureus
mono-species biofilms. However, when these same components
were degraded by DNase in the dual-species biofilm, we observed
a twofold increase in miconazole sensitivity, but no change when
treated in combination with the other enzymes (Table 2).
To determine whether C. albicans positively influenced this
dual-species interaction we next investigated the mechanistic
contribution of the ECM, hypothesizing that eDNA may be
pivotal factor in supporting the dual-species interactions, as has
been shown in mono-species C. albicans biofilms (Rajendran
et al., 2014). Figure 5A shows an increase of eDNA release into
the biofilm supernatant from dual-species biofilm compared to
a C. albicans biofilm in a time dependent manner. Throughout
the assessed time points, mono-species S. aureus biofilms eDNA
levels were below detectable limit. After 90 min of biofilm
development eDNA levels of all tested groups remained below
a detectable level. After 6 h of growth, there was no significant
difference between C. albicans and dual-species eDNA release
(p = 0.4296). At 12 h, a significant increase in the quantity of
eDNA released from the dual-species biofilm was observed (2.28-
fold, p < 0.05). After 24 h the quantity of eDNA released from
C. albicans biofilms plateaued, whereas the dual-species biofilm
continued to rise, with a significant increase (p< 0.01, 4.40-fold).
Finally, we next assessed if this secreted eDNA contributed to
the biofilm structure by measuring the eDNA quantity within the
ECM. It was shown that the ECM associated eDNA significantly
increased 2.15-fold when comparing the dual-species biofilm
to the C. albicans biofilm (P < 0.01; Figure 5B). We then
used qPCR to analyze the species contribution to this increase,
showing that in the dual-species biofilm both organisms released
significantly more eDNA than their mono-species counterparts.
The quantity of C. albicans eDNA significantly increased from
408.5 to 611.1 pg/mL in the co-culture (p < 0.05), with the
S. aureus eDNA also significantly increasing 4.7-fold (p < 0.001;
Figure 5C). Due to the increase of eDNA in the dual-species
biofilm we then investigated its role in supporting the adhesion
of S. aureus to a mature C. albicans biofilm. It was shown that a
4 h DNase treatment at 130 µg/mL did not have any detectable
effect on S. aureus adhesion compared to the control, whereas
when the DNase concentration was increased (650 µg/mL)
we observed a significant 26.5% reduction in the number of
S. aureus cells that adhered to the C. albicans biofilm (P < 0.05;
Figure 5D).
DISCUSSION
Polymicrobial infections are increasingly recognized as a
clinically important entities due to altered patient prognosis that
results in increased hospital stays and decreased antimicrobial
efficacy (Sancho et al., 2012). In this manuscript, we aimed
to characterize the inter-kingdom interactions between the two
most common nosocomial pathogens C. albicans and S. aureus,
and subsequently evaluate miconazole in vitro and in vivo
sensitivities, an antifungal with reported cross-kingdom efficacy.
Using this strategy it was shown that S. aureus is able to use
C. albicans as a physical scaffold to colonize and form biofilms
upon an existing biofilm, a phenomenon we have termed as
mycofilms. We also report a novel role for eDNA in promoting
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FIGURE 3 | Candida albicans and Staphylococcus aureus display synergistic pathogenicity and reduced miconazole sensitivity in vivo. C. albicans
(CA) and S. aureus (SA) were standardized to 5 × 105 CFU/larvae and administered to larvae as a mono or co-infection (CA+SA) with percentage survival monitored
across a 48 h period and data presented using a Kaplan Meier plot. Data are derived from three independent groups of 10 larvae with significance (∗p < 0.05,
∗∗p < 0.001) determined using the log-rank test in comparison between C. albicans and S. aureus alone and co-infection (A). After 24 h post-infection,
representative larvae were snap frozen in liquid nitrogen and DNA extracted. Microbial burden was then determined using qPCR and presented as CFE (B). Data are
derived from three larvae with ∗p < 0.05. Upon 2 h post-infection of larvae with 5 × 105 CFU/larvae with CA, SA, and co-infection (CA+SA), larvae were
administered with 75 mg/kg of miconazole. Percentage survival was monitored across a 48 h period and represented with a Kaplan Meier plot (C). Data represents
results from three independent groups of 10 larvae with significance achieved (∗∗p < 0.01, ∗∗∗p < 0.001) comparing C. albicans, S. aureus, and co-infection using
the log-rank test.
the stability of C. albicans/S. aureus biofilms that augments
biofilm mediated resistance to miconazole.
An initial objective from this series of studies was to create
a reliable functional assay to quantify and characterize the
interaction between C. albicans and S. aureus. It was our
hypothesis based on previous studies that C. albicans hyphae
are integral to supporting S. aureus biofilm formation (Peters
et al., 2012b). To test this hypothesis we used the biofilm
defective S. aureus Newman strain to determine whether the
presence of C. albicans could positively enhance its ability
to colonize and form biofilms. Indeed, our hypothesis was
confirmed with the observation that single S. aureus cells and
small clusters adhere to C. albicans germ tubes after only
90 min of growth, while synchronously enhancing overall
biomass, significantly increasing throughout biofilm maturation.
This is in line with previous reports predicting the initiation
of polymicrobial biofilm occurs upon initial C. albicans germ
tube formation (Harriott and Noverr, 2009), and continues as
the biofilm becomes fully mature (Peters et al., 2010). Given
that the ALS3 gene is highly expressed during early phases
of C. albicans filamentous growth during biofilm formation
(Sherry et al., 2014), then it is unsurprising that this key
biofilm adhesin is involved in mediating the initial attachment
of bacteria within the polymicrobial biofilm (Peters et al.,
2012b). Als3p shares between 80 and ≥95% homology with
collagen binding and clumping factor proteins of S. aureus
(Sheppard et al., 2004), therefore the cellular basis for these
interactions may be reciprocal. Indeed, the anti-candidal vaccine
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FIGURE 4 | Scanning electron micrograph of S. aureus colonizing
C. albicans hyphae within dual-species biofilms. Dual-species biofilms
were grown for 24 h before being fixed, processed, and imaged using a
JEOL-JSM 6400 scanning electron microscope. S. aureus colonies can be
seen adhering and embedded within the hyphal meshwork of C. albicans.
White arrows indicate clusters of S. aureus colonies encased within
extracellular matrix (ECM). Scale bar represents 5 µm at × 5000
magnification.
derived from the Als3p also protects against S. aureus infection
in a murine model (Spellberg et al., 2008). Interestingly, the
use of the biofilm defective Newman’s strain of S. aureus
suggests that this species does not necessarily require the full
armamentarium of biofilm-associated genes, as the presence
of a scaffold of C. albicans hyphae is capable of facilitating
the process, which may explain why these organisms as so
frequently co-isolated (Beenken et al., 2003). This may also
explain why there is such heterogeneity in terms of S. aureus
biofilm formation (Smith et al., 2008), a phenomenon also
evident in C. albicans biofilm formation (Sherry et al., 2014;
Rajendran et al., 2016a).
As C. albicans biofilm maturation progressed the quantities
of S. aureus was significantly enhanced, though notably there
was a significant increase in the number of dead C. albicans
cells, suggesting that S. aureus is able to utilize C. albicans in
some undefined way through this close interaction. Metabolomic
analysis of the interaction enabled us to recently identify that
S. aureus is able to consume sterols, products also found in
the secretome of C. albicans biofilms (Weidj et al., 2016).
Given that sterols have been shown to promote S. aureus
growth (Shine et al., 1993), then this suggests that sterol
consumption is a contributing factor to its increased growth
rates in the dual-species biofilm. Other metabolites, such as
the C. albicans secreted QS compound farnesol has also been
shown to modulate S. aureus behavior through inhibiting lipase
activity and biofilm formation, as well as improving its sensitivity
to gentamicin (Jabra-Rizk et al., 2006; Kuroda et al., 2007;
Unnanuntana et al., 2009). Collectively, these data indicate
that these organisms have the capacity to interact with one
another at the molecular level. Indeed, our studies demonstrated
that in the G. mellonella model there is enhanced virulence
in the dual-species infection compared to both mono-species
infections, which is in agreement with previous in vivo murine
studies also describing enhanced virulence of C. albicans and
S. aureus co-infection (Carlson, 1983; Peters and Noverr, 2013).
One interesting hypothesis is that S. aureus utilize C. albicans
hyphae as a transportation mechanism, much like a needlestick
injection, to mediate systemic infection throughout the host
(Schlecht et al., 2015). This may be the reasoning behind previous
findings reporting that bacteria were recovered from the kidneys
of an oral candidiasis co-infection model, whereas in the mono-
infection model no. S. aureus, were detected (Kong et al.,
2015).
Given the clinical implications of the co-infection, we
were then interested in evaluating miconazole as a treatment
possibility, which has been shown to possess cross-kingdom
efficacy (Boyen et al., 2012). Miconazole functions via a dual
mechanism by primarily interfering with lipid membranes
through the inhibition of ergosterol synthesis resulting in an
accumulation of sterol by-products that consequently prevents
cell growth (Vanden Bossche et al., 1990). Additionally, it
functions in the stimulation of reactive oxygen species (ROS)
promoting cell death (Kobayashi et al., 2002; Vandenbosch et al.,
2010). It was shown that 10-fold greater concentrations of
miconazole were required to induce an effect against the mono-
and dual-species biofilms compared to planktonic combinations,
and the MIC levels in dual-species were ultimately defined
by C. albicans (40 mg/L). As this was a simplified model
on plastics we also utilized a more representative 3D model
to determine the viable composition (Townsend et al., 2016),
where we showed significantly more viable S. aureus than
the mono-culture model. This resistance was also translated
into the in vivo model where reduced sensitivity was clearly
demonstrated, which we propose is facilitated by the candidal-
mediated protection, and in particular the ECM as has been
reported elsewhere (De Brucker et al., 2015; Kong et al.,
2016).
The presence of C. albicans ECM within the mixed-
species biofilm has been shown to protect S. aureus from
vancomycin treatment through concentrations escalating as high
as 1600 mg/mL (Harriott and Noverr, 2009). A recent study
has elaborated on this work, identifying fungal β-1,3-glucan
as a matrix component to which S. aureus can encase itself
within and decrease its susceptibility to vancomycin (Kong
et al., 2016). The C. albicans ECM (β-1,3-glucans) has also
been shown to increase resistance to ofloxacin within E. coli
dual-species biofilms (De Brucker et al., 2015). Interestingly
though, of all C. albicans ECM constituents tested, degradation
of eDNA using DNase was shown to be the second most
effective way of reducing ofloxacin tolerance in this dual-
species model. The presence of biofilm associated eDNA has
been identified and characterized in a range of bacterial and
fungal pathogens including both S. aureus and C. albicans
(Lister and Horswill, 2014; Rajendran et al., 2014). S. aureus
eDNA release has been extensively characterized (Memmi et al.,
2012), though eDNA release in the mixed species biofilm is
less well defined. Studies between C. albicans and Pseudomonas
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FIGURE 5 | Extracellular DNA contributes to inter-kingdom pathogenicity. Mono- and dual-species biofilms were seeded at 1 × 106 CFU/mL in black 96-well
plates and eDNA release at 1.5, 6, 12, and 24 h measured using a SYBR R© Green 1 based microplate fluorescence assay (MFA) in comparison to a standard curve
(A). Biofilms were washed with 0.2 M EDTA to remove the ECM and resulting eDNA quantified using the MFA described above in comparison to a standard curve
(B). ECM associated DNA was then precipitated from matrix extracts and species contributions were analyzed using qPCR (C). C. albicans only biofilms were grown
for 24 h in black 96-well plates. After washing biofilms were then treated with either 130 or 650 mg/L of DNase for 4 h. SYTO9 R© stained S. aureus cells (1 × 106
CFU/mL) were then added to the biofilm and incubated for 90 mins before being fluorescently quantified in comparison to an vehicle control treated biofilm (D). Data
represents duplicate samples from three independent experiments (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001).
aeruginosa revealed that secreted bacterial components are able
to induce fungal cell lysis, as well as modulating fungal virulence
(Gibson et al., 2009). While it is unlikely that S. aureus is
able to secrete reciprocal components to P. aeruginosa, it is
conceivable that as nutrients become sparse within mature
biofilms S. aureus may scavenge off the fungal cell wall to
utilize its own growth, as was reported through our metabolomic
analyses (Weidj et al., 2016). When we examined the release of
eDNA into the biofilm supernatant it was shown to be phase
dependent, with enhanced eDNA release from the dual-species
biofilms after 12 h, continuing to increase as biofilms matured,
and this increased for both organisms within the biofilm. In
fact, exogenous S. aureus genomic DNA has been shown to
positively impact C. albicans biofilm formation (Sapaar et al.,
2014).
This study demonstrates that enzymatic degradation of
eDNA of a C. albicans biofilm negatively affects S. aureus
adhesion, highlighting therapeutic potential. The effective
disruption of C. albicans matrix components to enhance
antimicrobial efficacy has also been demonstrated within
in vitro mono- and dual-species biofilms (Nett et al., 2007;
Rajendran et al., 2014; De Brucker et al., 2015; Kong
et al., 2016). The ability to de-stabilize biofilms through
degradation of eDNA make it an attractive therapeutic
target, especially in polymicrobial biofilms where they can
be used to sensitize co-colonizing bacteria. Further studies
of these agents are required to validate their efficacy in vivo.
The DNase Pulmozyme R© is currently used in combination
with antibiotics for cystic fibrosis treatment, with significant
reduction in the prevalence of S. aureus found within treated
patients compared to untreated controls (Frederiksen et al.,
2006).
To summarize, this manuscript reports the close association of
two commonly co-isolated nosocomial pathogens, and indicates
that S. aureus can utilize C. albicans biofilm architecture to
its advantage. We also demonstrate that miconazole resistance
within dual-species biofilms is supported by eDNA. Further
exploration of this intriguing relationship between these two
organisms will aid to a better understanding of their frequent co-
isolation from the human host, and may provide novel avenues
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of possible therapeutic strategies to combat inter-kingdom
biofilm infections, particularly those infections of a topical nature
such as wounds, diabetic foot ulcers, and angular cheilitis.
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